Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-15 10:14 am Sale | 2022-12-31 | 13G | Frazier Lifesciences Acquisition Corporation FLAC | Alyeska Investment Group, L.P. | 0 0.000% | -753,492 (Position Closed) | Filing History |
| 2022-12-01 4:51 pm Sale | 2022-11-22 | 13G | Frazier Lifesciences Acquisition Corporation FLAC | Flynn James E | 0 0.000% | -2,572,986 (Position Closed) | Filing History |
| 2022-11-25 1:43 pm Sale | 2022-11-22 | 13D | Frazier Lifesciences Acquisition Corporation FLAC | VIKING GLOBAL INVESTORS LP | 0 0.000% | -3,671,462 (Position Closed) | Filing History |
| 2022-11-23 4:11 pm Sale | 2022-11-22 | 13D | Frazier Lifesciences Acquisition Corporation FLAC | Frazier Lifesciences Sponsor LLC | 0 0.000% | -1,501,000 (Position Closed) | Filing History |
| 2022-11-14 4:44 pm Purchase | 2022-11-02 | 13G | Frazier Lifesciences Acquisition Corporation FLAC | Flynn James E | 2,572,986 17.340% | 2,572,986 (New Position) | Filing History |
| 2022-11-03 5:13 pm Purchase | 2022-11-02 | 13D | Frazier Lifesciences Acquisition Corporation FLAC | VIKING GLOBAL INVESTORS LP | 3,671,462 25.670% | 847,062 (+29.99%) | Filing History |
| 2022-11-02 08:22 am Purchase | 2022-11-01 | 13G | Frazier Lifesciences Acquisition Corporation FLAC | VIKING GLOBAL INVESTORS LP | 2,824,400 19.750% | 2,824,400 (New Position) | Filing History |
| 2022-09-20 06:06 am Unchanged | 2022-07-25 | 13D | Frazier Lifesciences Acquisition Corporation FLAC | Frazier Lifesciences Sponsor LLC | 1,501,000 10.500% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:45 pm Purchase | 2021-12-31 | 13G | Frazier Lifesciences Acquisition Corporation FLAC | Alyeska Investment Group, L.P. | 753,492 5.300% | 753,492 (New Position) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | Frazier Lifesciences Acquisition Corporation FLAC | RA CAPITAL MANAGEMENT LLC | 0 0.000% | -1,000,000 (Position Closed) | Filing History |
| 2022-02-14 06:19 am Sale | 2021-12-31 | 13G | Frazier Lifesciences Acquisition Corporation FLAC | CITADEL ADVISORS LLC | 553,480 3.900% | -3,967 (-0.71%) | Filing History |
| 2021-06-03 4:03 pm Purchase | 2021-05-24 | 13G | Frazier Lifesciences Acquisition Corporation FLAC | CITADEL ADVISORS LLC | 557,447 8.500% | 557,447 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Frazier Lifesciences Acquisition Corporation FLAC | RA CAPITAL MANAGEMENT LLC | 1,000,000 7.000% | 1,000,000 (New Position) | Filing History |
| 2021-01-27 4:48 pm Purchase | 2020-12-11 | 13D | Frazier Lifesciences Acquisition Corporation FLAC | Frazier Lifesciences Sponsor LLC | 1,501,000 10.500% | 1,501,000 (New Position) | Filing History |